Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
Oxidative stress is associated with different neurological and psychiatric diseases. Therefore, development of new pharmaceuticals targeting oxidative dysregulation might be a promising approach to treat these diseases. The G-protein coupled receptor 55 (GPR55) is broadly expressed in central nervou...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/53573912c7d940c28090b1526114831b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:53573912c7d940c28090b1526114831b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:53573912c7d940c28090b1526114831b2021-11-11T17:07:53ZTargeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR5510.3390/ijms2221116651422-00671661-6596https://doaj.org/article/53573912c7d940c28090b1526114831b2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11665https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Oxidative stress is associated with different neurological and psychiatric diseases. Therefore, development of new pharmaceuticals targeting oxidative dysregulation might be a promising approach to treat these diseases. The G-protein coupled receptor 55 (GPR55) is broadly expressed in central nervous tissues and cells and is involved in the regulation of inflammatory and oxidative cell homeostasis. We have recently shown that coumarin-based compounds enfold inverse agonistic activities at GPR55 resulting in the inhibition of prostaglandin E<sub>2</sub>. However, the antioxidative effects mediated by GPR55 were not evaluated yet. Therefore, we investigated the antioxidative effects of two novel synthesized coumarin-based compounds, KIT C and KIT H, in primary mouse microglial and human neuronal SK-N-SK cells. KIT C and KIT H show antioxidative properties in SK-N-SH cells as well as in primary microglia. In GPR55-knockout SK-N-SH cells, the antioxidative effects are abolished, suggesting a GPR55-dependent antioxidative mechanism. Since inverse agonistic GPR55 activation in the brain seems to be associated with decreased oxidative stress, KIT C and KIT H possibly act as inverse agonists of GPR55 eliciting promising therapeutic options for oxidative stress related diseases.Matthias ApweilerSoraya Wilke SalibaJana StreyczekThomas HurrleSimone GräßleStefan BräseBernd L. FiebichMDPI AGarticleoxidative stressGPR55coumarin-based compoundsROSinverse agonism8-Iso-PGF<sub>2α</sub>Biology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11665, p 11665 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
oxidative stress GPR55 coumarin-based compounds ROS inverse agonism 8-Iso-PGF<sub>2α</sub> Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
oxidative stress GPR55 coumarin-based compounds ROS inverse agonism 8-Iso-PGF<sub>2α</sub> Biology (General) QH301-705.5 Chemistry QD1-999 Matthias Apweiler Soraya Wilke Saliba Jana Streyczek Thomas Hurrle Simone Gräßle Stefan Bräse Bernd L. Fiebich Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55 |
description |
Oxidative stress is associated with different neurological and psychiatric diseases. Therefore, development of new pharmaceuticals targeting oxidative dysregulation might be a promising approach to treat these diseases. The G-protein coupled receptor 55 (GPR55) is broadly expressed in central nervous tissues and cells and is involved in the regulation of inflammatory and oxidative cell homeostasis. We have recently shown that coumarin-based compounds enfold inverse agonistic activities at GPR55 resulting in the inhibition of prostaglandin E<sub>2</sub>. However, the antioxidative effects mediated by GPR55 were not evaluated yet. Therefore, we investigated the antioxidative effects of two novel synthesized coumarin-based compounds, KIT C and KIT H, in primary mouse microglial and human neuronal SK-N-SK cells. KIT C and KIT H show antioxidative properties in SK-N-SH cells as well as in primary microglia. In GPR55-knockout SK-N-SH cells, the antioxidative effects are abolished, suggesting a GPR55-dependent antioxidative mechanism. Since inverse agonistic GPR55 activation in the brain seems to be associated with decreased oxidative stress, KIT C and KIT H possibly act as inverse agonists of GPR55 eliciting promising therapeutic options for oxidative stress related diseases. |
format |
article |
author |
Matthias Apweiler Soraya Wilke Saliba Jana Streyczek Thomas Hurrle Simone Gräßle Stefan Bräse Bernd L. Fiebich |
author_facet |
Matthias Apweiler Soraya Wilke Saliba Jana Streyczek Thomas Hurrle Simone Gräßle Stefan Bräse Bernd L. Fiebich |
author_sort |
Matthias Apweiler |
title |
Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55 |
title_short |
Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55 |
title_full |
Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55 |
title_fullStr |
Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55 |
title_full_unstemmed |
Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55 |
title_sort |
targeting oxidative stress: novel coumarin-based inverse agonists of gpr55 |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/53573912c7d940c28090b1526114831b |
work_keys_str_mv |
AT matthiasapweiler targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55 AT sorayawilkesaliba targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55 AT janastreyczek targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55 AT thomashurrle targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55 AT simonegraßle targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55 AT stefanbrase targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55 AT berndlfiebich targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55 |
_version_ |
1718432176695934976 |